SCHEMBL19962800

SCHEMBL19962800

[N-]=[N+]=NC12O[C@@H](c3csc4c(N)nc(F)nc34)[C@H](F)[C@@]1(O)[C@@H]2O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20642796 1.00 — —
SCHEMBL19644592 0.86 HIF1A (0.30) —
SCHEMBL21880486 0.76 — —
SCHEMBL19644580 0.74 HIF1A (0.30) —
SCHEMBL21880622 0.73 HIF1A (0.30) —
SCHEMBL20959986 0.73 POLRMT (0.34) —
SCHEMBL19778892 0.73 POLRMT (0.34) —
SCHEMBL19644600 0.68 POLRMT (0.36) —
SCHEMBL19644567 0.67 — —
SCHEMBL20756525 0.67 POLRMT (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072755-A1 THIENO[3,2-d]PYRIMIDINE, FURO[3,2-d]PYRIMIDINE, AND PYRROLO[3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES, INC. 2018-03-15 — — US disclosed
Send feedback